Sign In
Buy TNYA
$0.731
+0.0191 (+2.68%)
At Close: Jun 18, 2026
Tenaya Therapeutics (NASDAQ:TNYA) Shares Gap Down to $26.76
04:40pm, Monday, 15'th Nov 2021 Dakota Financial News
Tenaya Therapeutics Inc (NASDAQ:TNYA) shares gapped down prior to trading on Monday . The stock had previously closed at $26.76, but opened at $25.85. Tenaya Therapeutics shares last traded at $25.93, with a volume of 145 shares trading hands. TNYA has been the topic of several recent analyst reports. Cowen initiated coverage on shares of []
Tenaya Therapeutics to Present Preclinical Data on Its Gene Therapy Programs at the ESGCT 28th Annual Congress
06:05pm, Tuesday, 12'th Oct 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tenaya Therapeutics announced today that it will present new preclinical data at the ESGCT 28th Annual Congress.
Tenaya Therapeutics to Participate in Upcoming Investor and Industry Conferences
06:02pm, Thursday, 30'th Sep 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $TNYA--Tenaya Therapeutics announced today that Faraz Ali, Chief Executive Officer, will participate in upcoming investor and industry conferences.
Tenaya Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates
04:00pm, Wednesday, 08'th Sep 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $TNYA--Tenaya Therapeutics reported business and program updates and second quarter 2021 financial results.
Tenaya Therapeutics: Treating Heart Disease Through 3 Product Platforms
06:29am, Friday, 06'th Aug 2021
Tenaya Therapeutics is developing therapies for rare genetic disorders and more prevalent cardiovascular diseases.
